What are the opening hours?

Monday 8:30am - 5pm Tuesday 8:30am - 5pm Wednesday 8:30am - 5pm Thursday 8:30am - 5pm Friday 8:30am - 5pm

Cellvizio by Mauna Kea Technologies

Home
United States
Boston, MA
Cellvizio by Mauna Kea Technologies

Cellvizio is the real-time in vivo cellular imaging platform that revolutionizes the way physicians

Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative change in medicine.

12/30/2025

We are wrapping up a milestone year for Mauna Kea Technologies, and as we close out the year we wish you and your loved ones safe and healthy holidays.

12/29/2025

Conventional imaging and fluid analysis for often leave physicians in the dark, leading to misdiagnosis or unnecessary, high-risk surgeries. As highlighted in this study, needle-based Confocal Laser Endomicroscopy ( ) using AI enables more precise clinical decision-making, ensuring that surgical interventions are reserved for those who truly need them.

Read the full publication: https://hubs.la/Q03Z7t0J0

12/23/2025

We want to take a moment to express our immense gratitude to everyone who made 2025 a transformational year here at MKT! Together, we are on a mission to revolutionize the world of healthcare by advancing how physicians diagnose and treat patients using the incredible technology of Cellvizio advanced imaging.

12/18/2025

We are thrilled to announce is expanding to University Hospital of Vienna!

This groundbreaking program, led by Prof. Johann Hammer, marks a significant step forward in patient care and research. Prof. Hammer and his team will be utilizing the CellTolerance test for patients suffering from food-related .

12/17/2025

We are honored to partner with Henry Ford Health as they integrate nCLE into their standard clinical workflow.

By bringing cellular visualization directly into the endoscopy suite, the Henry Ford team is moving beyond traditional imaging. This enables real-time, cellular-level insights inside pancreatic cysts, empowering clinicians to make more confident diagnoses and tailor treatment plans faster than ever before.

12/16/2025

With a focus on reducing unnecessary procedures and enhancing patient outcomes, integrates into any healthcare system and paves the way for more precise, effective healthcare.

Know the latest updates on nCLE in Pancreatic Cysts: https://hubs.la/Q03XkYLh0

12/11/2025

Mauna Kea Technologies and TaeWoong Medical USA are bringing the first fully integrated "imaging-to-therapy" solution for pancreatic cystic lesions to the U.S.

One seamless workflow combining real-time cellular imaging with advanced therapeutic tools, empowering physicians with enhanced precision while reducing unnecessary surgeries.

Read the full PR: https://hubs.la/Q03XyJsw0

12/09/2025

Exciting developments in pancreatic cyst diagnostics! When combining with traditional methods, diagnostic accuracy soars. This kind of precision is transforming how we approach patient care.

Learn more: https://hubs.la/Q03XfF4g0

12/04/2025

Crohn’s Disease and Ulcerative Colitis are two chronic inflammatory bowel diseases ( ) that affect millions of people around the world. While not showing any outward signs of their condition, many struggle to get the support and understanding that they need.

To learn how can be superior to conventional severity scoring, visit: https://hubs.la/Q03WSQNs0

Crohn's & Colitis Foundation

12/03/2025

We announce an exclusive partnership between Mauna Kea Technologies and TaeWoong Medical USA to revolutionize pancreatic cyst management in the United States.

Together, we're introducing the industry's first fully integrated "imaging-to-therapy" solution for pancreatic cystic lesions. This partnership unites real-time cellular-level imaging with advanced diagnostic and therapeutic instruments in one streamlined workflow, delivering end-to-end patient management from diagnosis through intervention while minimizing unnecessary surgeries.

By combining Mauna Kea's diagnostic technology with TaeWoong's therapeutic expertise and U.S. commercial infrastructure, we're empowering physicians with unprecedented clarity and control in EUS-guided pancreatic care.

Learn more: https://hubs.la/Q03WKCSf0

12/01/2025

Learn more about the cost-benefit of using nCLE in an EUS-FNA procedure: https://hubs.la/Q03WgtSn0

11/26/2025

It is no coincidence that falls during the Thanksgiving holiday. Chronic reflux can be a signal that there is more going on beneath the surface.

Explore our educational resources for the best understanding of these conditions:https://hubs.la/Q03VHbtv0

Address

24 Denby Road, Suite 140
Boston, MA
02134

Opening Hours

Monday	8:30am - 5pm
Tuesday	8:30am - 5pm
Wednesday	8:30am - 5pm
Thursday	8:30am - 5pm
Friday	8:30am - 5pm

Website

http://www.maunakeatech.com/

Alerts

Be the first to know and let us send you an email when Cellvizio by Mauna Kea Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Boston?

Our Story

Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The Company’s flagship product, Cellvizio®, has received clearance/approval in a wide range of applications in more than 40 countries, including the United States, Europe, Japan, China, Canada, Brazil and Mexico.